Skip to main content
Erschienen in: Journal of Clinical Immunology 6/2020

06.06.2020 | Original Article

Clinical Phenotypes and Immunological Characteristics of 18 Egyptian LRBA Deficiency Patients

verfasst von: Safa Meshaal, Rabab El Hawary, Rana Adel, Dalia Abd Elaziz, Aya Erfan, Sohilla Lotfy, Mona Hafez, Mona Hassan, Matthew Johnson, Jessica Rojas-Restrepo, Laura Gamez-Diaz, Bodo Grimbacher, Walaa Shoman, Yasmine Abdelmeguid, Jeannette Boutros, Nermeen Galal, Nancy El-Guindy, Aisha Elmarsafy

Erschienen in: Journal of Clinical Immunology | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

LPS-responsive beige-like anchor (LRBA) deficiency is an autosomal recessive primary immunodeficiency disorder, OMIM (#614700). LRBA deficiency patients suffer from variable manifestations including recurrent infections, immune dysregulation, autoimmunity, cytopenias, and enteropathy. This study describes different clinical phenotypes and immunological characteristics of 18 LRBA deficiency patients diagnosed from Egypt. T and B lymphocyte subpopulations, LRBA, and cytotoxic T lymphocyte-associated protein 4 (CTLA4) expression were evaluated in resting and stimulated T cells using flow cytometry. Next-generation sequencing was used to identify mutations in the LRBA gene. LRBA deficiency patients had significantly lower B cells and increased percentage of memory T cells. CTLA4 levels were lower in LRBA-deficient T regulatory cells in comparison to healthy donors at resting conditions and significantly increased upon stimulation of T cells. We identified 11 novel mutations in LRBA gene ranging from large deletions to point mutations. Finally, we were able to differentiate LRBA-deficient patients from healthy control and common variable immunodeficiency patients using a simple flow cytometry test performed on whole blood and without need to prior stimulation. LRBA deficiency has heterogeneous phenotypes with poor phenotype-genotype correlation since the same mutation may manifest differently even within the same family. Low LRBA expression, low numbers of B cells, increased numbers of memory T cells, and defective CTLA4 expression (which increase to normal level upon T cell stimulation) are useful laboratory tests to establish the diagnosis of LRBA deficiency. Screening of the siblings of affected patients is very important as patients may be asymptomatic at the beginning of the disease course.
Literatur
1.
Zurück zum Zitat Kiykim A, Ogulur I, Dursun E, Charbonnier LM, Nain E, Cekic S, et al. Abatacept as a long-term targeted therapy for LRBA deficiency. J Allergy Clin Immunol Pract. 2019;7(8):2790–800.CrossRef Kiykim A, Ogulur I, Dursun E, Charbonnier LM, Nain E, Cekic S, et al. Abatacept as a long-term targeted therapy for LRBA deficiency. J Allergy Clin Immunol Pract. 2019;7(8):2790–800.CrossRef
2.
Zurück zum Zitat Burnett DL, Parish IA, Masle-Farquhar E, Brink R, Goodnow CC. Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation. Immunol Cell Biol. 2017;95(9):775–88.CrossRef Burnett DL, Parish IA, Masle-Farquhar E, Brink R, Goodnow CC. Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation. Immunol Cell Biol. 2017;95(9):775–88.CrossRef
3.
Zurück zum Zitat Lo B, Zhang K, Lu W, Zheng L, Zhang Q, Kanellopoulou C, et al. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science. 2015;349(6246):436–40.CrossRef Lo B, Zhang K, Lu W, Zheng L, Zhang Q, Kanellopoulou C, et al. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science. 2015;349(6246):436–40.CrossRef
4.
Zurück zum Zitat Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science. 2011;332(6029):600–3.CrossRef Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science. 2011;332(6029):600–3.CrossRef
5.
Zurück zum Zitat Charbonnier L-M, Janssen E, Chou J, Ohsumi TK, Keles S, Hsu JT, et al. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked–like disorder caused by loss-of-function mutations in LRBA. Journal of Allergy and Clinical Immunology. 2015;135(1):217–27. e9. Charbonnier L-M, Janssen E, Chou J, Ohsumi TK, Keles S, Hsu JT, et al. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked–like disorder caused by loss-of-function mutations in LRBA. Journal of Allergy and Clinical Immunology. 2015;135(1):217–27. e9.
6.
Zurück zum Zitat Schubert D, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med. 2014;20(12):1410–6.CrossRef Schubert D, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med. 2014;20(12):1410–6.CrossRef
7.
Zurück zum Zitat Alangari A, Alsultan A, Adly N, Massaad MJ, Kiani IS, Aljebreen A, et al. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. Journal of Allergy and Clinical Immunology. 2012;130(2):481–8. e2. Alangari A, Alsultan A, Adly N, Massaad MJ, Kiani IS, Aljebreen A, et al. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. Journal of Allergy and Clinical Immunology. 2012;130(2):481–8. e2.
8.
Zurück zum Zitat Bal SK, Haskologlu S, Serwas NK, Islamoglu C, Aytekin C, Kendirli T, et al. Multiple presentations of LRBA deficiency: a single-center experience. J Clin Immunol. 2017;37(8):790–800.CrossRef Bal SK, Haskologlu S, Serwas NK, Islamoglu C, Aytekin C, Kendirli T, et al. Multiple presentations of LRBA deficiency: a single-center experience. J Clin Immunol. 2017;37(8):790–800.CrossRef
9.
Zurück zum Zitat Gámez-Díaz L, August D, Stepensky P, Revel-Vilk S, Seidel MG, Noriko M, et al. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency. J Allergy Clin Immunol. 2016;137(1):223–30.CrossRef Gámez-Díaz L, August D, Stepensky P, Revel-Vilk S, Seidel MG, Noriko M, et al. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency. J Allergy Clin Immunol. 2016;137(1):223–30.CrossRef
10.
Zurück zum Zitat Azizi G, Abolhassani H, Habibi S, Rahamooz T, Mohammadi H, Jafarnezhad-Ansariha F, et al. Two faces of LRBA deficiency in siblings: hypogammaglobulinemia and normal immunoglobulin levels. J Investig Allergol Clin Immunol. 2018;28(1):48–50.CrossRef Azizi G, Abolhassani H, Habibi S, Rahamooz T, Mohammadi H, Jafarnezhad-Ansariha F, et al. Two faces of LRBA deficiency in siblings: hypogammaglobulinemia and normal immunoglobulin levels. J Investig Allergol Clin Immunol. 2018;28(1):48–50.CrossRef
11.
Zurück zum Zitat Gámez-Díaz L, Sigmund EC, Reiser V, Vach W, Jung S, Grimbacher B. Rapid flow cytometry-based test for the diagnosis of lipopolysaccharide responsive beige-like anchor (LRBA) deficiency. Front Immunol. 2018;9. Gámez-Díaz L, Sigmund EC, Reiser V, Vach W, Jung S, Grimbacher B. Rapid flow cytometry-based test for the diagnosis of lipopolysaccharide responsive beige-like anchor (LRBA) deficiency. Front Immunol. 2018;9.
12.
Zurück zum Zitat Habibi S, Zaki-Dizaji M, Rafiemanesh H, Lo B, Jamee M, Gámez-Díaz L, et al. Clinical, immunologic, and molecular spectrum of patients with LPS-responsive beige-like anchor protein deficiency: a systematic review. J Allergy Clin Immunol Pract. 2019;7(7):2379–86.13.CrossRef Habibi S, Zaki-Dizaji M, Rafiemanesh H, Lo B, Jamee M, Gámez-Díaz L, et al. Clinical, immunologic, and molecular spectrum of patients with LPS-responsive beige-like anchor protein deficiency: a systematic review. J Allergy Clin Immunol Pract. 2019;7(7):2379–86.13.CrossRef
13.
Zurück zum Zitat Liphaus BL, Caramalho I, Rangel-Santos A, Silva CA, Demengeot J, Carneiro-Sampaio MM. LRBA deficiency: a new genetic cause of monogenic lupus. Ann Rheum Dis. 2020;79(3):427–8.CrossRef Liphaus BL, Caramalho I, Rangel-Santos A, Silva CA, Demengeot J, Carneiro-Sampaio MM. LRBA deficiency: a new genetic cause of monogenic lupus. Ann Rheum Dis. 2020;79(3):427–8.CrossRef
14.
Zurück zum Zitat Taylan C, Wenzel A, Erger F, Göbel H, Weber LT, Beck BB. Case report: exome sequencing reveals LRBA deficiency in a patient with end-stage renal disease. Front Pediatr. 2020;8. Taylan C, Wenzel A, Erger F, Göbel H, Weber LT, Beck BB. Case report: exome sequencing reveals LRBA deficiency in a patient with end-stage renal disease. Front Pediatr. 2020;8.
15.
Zurück zum Zitat Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112(5):973–80.CrossRef Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112(5):973–80.CrossRef
16.
Zurück zum Zitat Wallach JB. Interpretation of diagnostic tests: Lippincott Williams & Wilkins; 2007. Wallach JB. Interpretation of diagnostic tests: Lippincott Williams & Wilkins; 2007.
17.
Zurück zum Zitat De Bruyne M, Bogaert DJ, Venken K, Van den Bossche L, Bonroy C, Roels L, et al. A novel LPS-responsive beige-like anchor protein (LRBA) mutation presents with normal cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and overactive TH17 immunity. J Allergy Clin Immunol. 2018. De Bruyne M, Bogaert DJ, Venken K, Van den Bossche L, Bonroy C, Roels L, et al. A novel LPS-responsive beige-like anchor protein (LRBA) mutation presents with normal cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and overactive TH17 immunity. J Allergy Clin Immunol. 2018.
18.
Zurück zum Zitat Serwas NK, Kansu A, Santos-Valente E, Kuloğlu Z, Demir A, Yaman A, et al. Atypical manifestation of LRBA deficiency with predominant IBD-like phenotype. Inflamm Bowel Dis. 2014;21(1):40–7.CrossRef Serwas NK, Kansu A, Santos-Valente E, Kuloğlu Z, Demir A, Yaman A, et al. Atypical manifestation of LRBA deficiency with predominant IBD-like phenotype. Inflamm Bowel Dis. 2014;21(1):40–7.CrossRef
19.
Zurück zum Zitat Revel-Vilk S, Fischer U, Keller B, Nabhani S, Gámez-Díaz L, Rensing-Ehl A, et al. Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation. Clin Immunol. 2015;159(1):84–92.CrossRef Revel-Vilk S, Fischer U, Keller B, Nabhani S, Gámez-Díaz L, Rensing-Ehl A, et al. Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation. Clin Immunol. 2015;159(1):84–92.CrossRef
20.
Zurück zum Zitat Azizi G, Abolhassani H, Mahdaviani SA, Chavoshzadeh Z, Eshghi P, Yazdani R, et al. Clinical, immunologic, molecular analyses and outcomes of Iranian patients with LRBA deficiency: a longitudinal study. Pediatr Allergy Immunol. 2017;28(5):478–84.CrossRef Azizi G, Abolhassani H, Mahdaviani SA, Chavoshzadeh Z, Eshghi P, Yazdani R, et al. Clinical, immunologic, molecular analyses and outcomes of Iranian patients with LRBA deficiency: a longitudinal study. Pediatr Allergy Immunol. 2017;28(5):478–84.CrossRef
21.
Zurück zum Zitat Tesch VK, Abolhassani H, Shadur B, Zobel J, Mareika Y, Sharapova S, Karakoc-Aydiner E, Rivière JG, Garcia-Prat M, Moes N, Haerynck F. Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score. J Allergy Clin Immunol 2019 27. Tesch VK, Abolhassani H, Shadur B, Zobel J, Mareika Y, Sharapova S, Karakoc-Aydiner E, Rivière JG, Garcia-Prat M, Moes N, Haerynck F. Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score. J Allergy Clin Immunol 2019 27.
22.
Zurück zum Zitat Alkhairy OK, Abolhassani H, Rezaei N, Fang M, Andersen KK, Chavoshzadeh Z, et al. Spectrum of phenotypes associated with mutations in LRBA. J Clin Immunol. 2016;36(1):33–45.CrossRef Alkhairy OK, Abolhassani H, Rezaei N, Fang M, Andersen KK, Chavoshzadeh Z, et al. Spectrum of phenotypes associated with mutations in LRBA. J Clin Immunol. 2016;36(1):33–45.CrossRef
23.
Zurück zum Zitat Al Sukaiti N, AbdelRahman K, AlShekaili J, Al Oraimi S, Al Sinani A, Al Rahbi N, et al. Agammaglobulinaemia despite terminal B-cell differentiation in a patient with a novel LRBA mutation. Clinical & translational immunology. 2017;6(5):e144.CrossRef Al Sukaiti N, AbdelRahman K, AlShekaili J, Al Oraimi S, Al Sinani A, Al Rahbi N, et al. Agammaglobulinaemia despite terminal B-cell differentiation in a patient with a novel LRBA mutation. Clinical & translational immunology. 2017;6(5):e144.CrossRef
24.
Zurück zum Zitat Lopez-Herrera G, Tampella G, Pan-Hammarström Q, Herholz P, Trujillo-Vargas CM, Phadwal K, et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet. 2012;90(6):986–1001.CrossRef Lopez-Herrera G, Tampella G, Pan-Hammarström Q, Herholz P, Trujillo-Vargas CM, Phadwal K, et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet. 2012;90(6):986–1001.CrossRef
25.
Zurück zum Zitat Bhargava P, Calabresi P. Novel therapies for memory cells in autoimmune diseases. Clinical & Experimental Immunology. 2015;180(3):353–60.CrossRef Bhargava P, Calabresi P. Novel therapies for memory cells in autoimmune diseases. Clinical & Experimental Immunology. 2015;180(3):353–60.CrossRef
26.
Zurück zum Zitat Elaziz DSA, Hafez MH, Galal NM, Meshaal SS, El Marsafy AM. CD4+ CD25+ cells in type 1 diabetic patients with other autoimmune manifestations. J Adv Res. 2014;5(6):647–55.CrossRef Elaziz DSA, Hafez MH, Galal NM, Meshaal SS, El Marsafy AM. CD4+ CD25+ cells in type 1 diabetic patients with other autoimmune manifestations. J Adv Res. 2014;5(6):647–55.CrossRef
27.
Zurück zum Zitat Johnson MB, De Franco E, Allen HL, Al Senani A, Elbarbary N, Siklar Z, et al. Recessively inherited LRBA mutations cause autoimmunity presenting as neonatal diabetes. Diabetes. 2017;66(8):2316–22.CrossRef Johnson MB, De Franco E, Allen HL, Al Senani A, Elbarbary N, Siklar Z, et al. Recessively inherited LRBA mutations cause autoimmunity presenting as neonatal diabetes. Diabetes. 2017;66(8):2316–22.CrossRef
28.
Zurück zum Zitat Azizi G, Abolhassani H, Kiaee F, Tavakolinia N, Rafiemanesh H, Yazdani R, et al. Autoimmunity and its association with regulatory T cells and B cell subsets in patients with common variable immunodeficiency. Allergol Immunopathol. 2018;46(2):127–35.CrossRef Azizi G, Abolhassani H, Kiaee F, Tavakolinia N, Rafiemanesh H, Yazdani R, et al. Autoimmunity and its association with regulatory T cells and B cell subsets in patients with common variable immunodeficiency. Allergol Immunopathol. 2018;46(2):127–35.CrossRef
29.
Zurück zum Zitat Hou TZ, Verma N, Wanders J, Kennedy A, Soskic B, Janman D, et al. Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations. Blood. 2017:blood-2016-10-745174. Hou TZ, Verma N, Wanders J, Kennedy A, Soskic B, Janman D, et al. Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations. Blood. 2017:blood-2016-10-745174.
30.
Zurück zum Zitat Gámez-Díaz L, Neumann J, Jäger F, Proietti M, Felber F, Soulas-Sprauel P, et al. Immunological phenotype of the murine Lrba knockout. Immunol Cell Biol. 2017;95(9):789–802.CrossRef Gámez-Díaz L, Neumann J, Jäger F, Proietti M, Felber F, Soulas-Sprauel P, et al. Immunological phenotype of the murine Lrba knockout. Immunol Cell Biol. 2017;95(9):789–802.CrossRef
31.
Zurück zum Zitat El Hawary R, Meshaal S, Deswarte C, Galal N, Abdelkawy M, Alkady R, et al. Role of flow cytometry in the diagnosis of chronic granulomatous disease: the Egyptian experience. J Clin Immunol. 2016;36(6):610–8.CrossRef El Hawary R, Meshaal S, Deswarte C, Galal N, Abdelkawy M, Alkady R, et al. Role of flow cytometry in the diagnosis of chronic granulomatous disease: the Egyptian experience. J Clin Immunol. 2016;36(6):610–8.CrossRef
32.
Zurück zum Zitat Jaramillo CM, Trujillo-Vargas CM. LRBA en el sistema de endomembranas. Colombia Medica. 2018;49(3):236–44.CrossRef Jaramillo CM, Trujillo-Vargas CM. LRBA en el sistema de endomembranas. Colombia Medica. 2018;49(3):236–44.CrossRef
33.
Zurück zum Zitat Meshaal SS, El Hawary RE, Eldash A, Grimbacher B, Camacho-Ordonez N, Elaziz DSA, et al. Diagnosis of DOCK8 deficiency using flow cytometry biomarkers: an Egyptian center experience. Clin Immunol. 2018;195:36–44.CrossRef Meshaal SS, El Hawary RE, Eldash A, Grimbacher B, Camacho-Ordonez N, Elaziz DSA, et al. Diagnosis of DOCK8 deficiency using flow cytometry biomarkers: an Egyptian center experience. Clin Immunol. 2018;195:36–44.CrossRef
Metadaten
Titel
Clinical Phenotypes and Immunological Characteristics of 18 Egyptian LRBA Deficiency Patients
verfasst von
Safa Meshaal
Rabab El Hawary
Rana Adel
Dalia Abd Elaziz
Aya Erfan
Sohilla Lotfy
Mona Hafez
Mona Hassan
Matthew Johnson
Jessica Rojas-Restrepo
Laura Gamez-Diaz
Bodo Grimbacher
Walaa Shoman
Yasmine Abdelmeguid
Jeannette Boutros
Nermeen Galal
Nancy El-Guindy
Aisha Elmarsafy
Publikationsdatum
06.06.2020
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 6/2020
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-020-00799-2

Weitere Artikel der Ausgabe 6/2020

Journal of Clinical Immunology 6/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.